Epigenetic modifications induced by RGC-32 in colon cancer

First described as a cell cycle activator, RGC-32 is both an activator and a substrate for CDC2. Deregulation of RGC-32 expression has been detected in a wide variety of human cancers. We have now shown that RGC-32 is expressed in precancerous states, and its expression is significantly higher in ad...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Vlaicu, Sonia I., Tegla, Cosmin A., Cudrici, Cornelia D., Fosbrink, Matthew, Nguyen, Vingh, Azimzadeh, Philippe, Rus, Violeta, Chen, Hegang, Mircea, Petru A., Shamsuddin, Abulkalam, Rus, Horea
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2009
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2815209/
https://ncbi.nlm.nih.gov/pubmed/19883641
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.yexmp.2009.10.010
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller